105 related articles for article (PubMed ID: 2945684)
1. Serum IgA levels and ANA behaviour in rheumatoid patients with and without toxicity to remission-inducing drugs.
Ferraccioli GF; Nervetti A; Mercadanti M; Cavalieri F
Clin Exp Rheumatol; 1986; 4(3):217-20. PubMed ID: 2945684
[TBL] [Abstract][Full Text] [Related]
2. Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens.
Ferraccioli G; Peri F; Nervetti A; Ambanelli U; Savi M
J Rheumatol; 1986 Feb; 13(1):65-8. PubMed ID: 3084782
[TBL] [Abstract][Full Text] [Related]
3. Association between DR3 and thrombocytopenia due to gold or tiopronin. Case reports and review of the literature.
Ferraccioli GF; Cavalieri F; Mercadanti M; Salaffi F; Ambanelli U; Savi M
Clin Exp Rheumatol; 1985; 3(4):341-3. PubMed ID: 3910323
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome with gold thiosulphate and tiopronin in 200 rheumatoid patients.
Ferraccioli GF; Salaffi F; Nervetti A; Manganelli P
Clin Exp Rheumatol; 1989; 7(6):577-81. PubMed ID: 2515016
[TBL] [Abstract][Full Text] [Related]
5. [Rare side effects of gold].
Stollenwerk R; Annefeld M; Schilling F; Dreher R
Z Rheumatol; 1986; 45(3):107-10. PubMed ID: 2944309
[TBL] [Abstract][Full Text] [Related]
6. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
Tumiati B; Veneziani M; Bellelli A; Portioli I
J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
[No Abstract] [Full Text] [Related]
7. Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics.
Ferraccioli GF; Peri F; Nervetti A; Mercadanti M; Cavalieri F; Dall'Aglio PP; Savi M; Ferrari C
Clin Exp Rheumatol; 1986; 4(1):9-15. PubMed ID: 3516496
[TBL] [Abstract][Full Text] [Related]
8. [Myasthenia caused by tiopronin during treatment of rheumatoid polyarthritis].
Menkes CJ; Job-Deslandre C; Bauer-Vinassac D; Rouillon A; Rousseau R
Presse Med; 1988 Jun; 17(22):1156-7. PubMed ID: 2969543
[No Abstract] [Full Text] [Related]
9. [A study of drug eruptions due to tiopronin].
Ichikawa S; Shida Y; Nagano I; Shimizu M
Nihon Hifuka Gakkai Zasshi; 1988 Jan; 98(1):1-8. PubMed ID: 2969988
[No Abstract] [Full Text] [Related]
10. Lupus like syndrome induced by 2-mercaptopropionylglycine.
Katayama I; Nishioka K
J Dermatol; 1986 Apr; 13(2):151-3. PubMed ID: 3531274
[No Abstract] [Full Text] [Related]
11. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis.
Amor B; Mery C; de Gery A
Arthritis Rheum; 1982 Jun; 25(6):698-703. PubMed ID: 7046758
[TBL] [Abstract][Full Text] [Related]
12. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis.
Trotta F; Scaramelli M; Cervi G; Virgili AR
Scand J Rheumatol; 1984; 13(1):93-5. PubMed ID: 6719065
[TBL] [Abstract][Full Text] [Related]
13. [Lichen ruber pemphigoid in gold treatment of rheumatoid arthritis].
Wozel G; Rietzschel I; Heidenbluth I
Dermatol Monatsschr; 1983 Feb; 169(2):125-9. PubMed ID: 6404668
[No Abstract] [Full Text] [Related]
14. [Extracapillary proliferative glomerulonephritis and pulmonary purpura in a patient with rheumatoid arthritis treated with gold salts].
Bontempini L; Colombari R; Lupo A; Malena M; Doglioni C; Ghimenton C
Pathologica; 1986; 78(1057):647-55. PubMed ID: 3114704
[No Abstract] [Full Text] [Related]
15. Absence of gold sodium thiosulfate contact hypersensitivity in rheumatoid arthritis.
Fleming C; Porter D; MacKie R
Contact Dermatitis; 1998 Jan; 38(1):55-6. PubMed ID: 9504259
[No Abstract] [Full Text] [Related]
16. [Oral lichenoid reaction secondary to gold salt therapy].
Vallejo Irastorza G; López Cedrún JL; Marínez-Conde R; Aguirre Urízar JM
Av Odontoestomatol; 1990 Feb; 6(2):131-3. PubMed ID: 2118353
[TBL] [Abstract][Full Text] [Related]
17. Primary biliary cirrhosis. A patient with adverse reactions to tiopronin and autoimmune hemolytic anemia with reticulocytopenia.
Shichiri M; Koyama W; Tozuka S; Sakamoto S; Kanayama M
Arch Intern Med; 1984 Jan; 144(1):89-91. PubMed ID: 6229229
[TBL] [Abstract][Full Text] [Related]
18. [2 cases of kidney damage during the treatment with gold preparations].
Wanic-Kossowska M; Turczak-Bierła I; Grzegorzewska A
Przegl Lek; 1990; 47(11):788-90. PubMed ID: 2129137
[No Abstract] [Full Text] [Related]
19. Hypersensitivity to gold in gold sodium thiomalate-induced dermatosis.
Räsänen L; Kaipiainen-Seppänen O; Myllykangas-Luosujärvi R; Käsnänen T; Pollari P; Saloranta P; Horsmanheimo M
Br J Dermatol; 1999 Oct; 141(4):683-8. PubMed ID: 10583116
[TBL] [Abstract][Full Text] [Related]
20. Hypogammaglobulinaemia associated with gold therapy.
Hunter T
Ann Rheum Dis; 1985 Mar; 44(3):212. PubMed ID: 3919662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
